In the first such judgment since the 1980s, Justice Moshinsky has granted an interlocutory injunction to prevent TMA...

Home / News / Pearce IP Blog
In the first such judgment since the 1980s, Justice Moshinsky has granted an interlocutory injunction to prevent TMA...
31 March 22 | Fresenius Kabi announced that it has bought a majority stake (55%) in mAbxience, a company specialising...
In its 2022-23 Budget, the Coalition Government has stated that it will continue to fund litigation against originator...
28 Mar 22 | Aurobindo announced that it will acquire certain business assets from Veritaz (the supplier of branded...
In the Coalition Government’s Budget for the financial year 2022-23, it sets out the investments that it would make...
19 Mar 22 | US | Amgen and Pfizer settled their pegfilgrastim (Neulasta®) dispute Amgen Inc v Hospira Inc (D. Del.,...
14 Mar 22 | OcyonBio announced that it has entered into a manufacturing and operations agreement with Biosimilar...
Introduction The decision of the High Court in H. Lundbeck A/S v Sandoz Pty Ltd [2022] HCA 4 (Lundbeck) last week...
03 Mar 22 | US | FDA announced a new funding opportunity for the BsUFA III Regulatory Science Program to support...
We previously wrote that, from 24 March 2022, individuals, businesses and organisations with an Australian presence...
18 Feb 22 | Celltrion released two data sets on the subcutaneous (SC) form of Remsima® (biosimilar infliximab)....
11 Apr 22 | CA | Celltrion announced the launch of Yuflyma® (high-concentration, low-volume, citrate-free and...
07 Feb 22 | The International Generic and Biosimilar medicines Association (IGBA) announced that it has established a...
01 Feb 22 | JAMP Pharma announced the creation of a new division BIOJAMP™ dedicated to biosimilars. The creation of...
18 Jan 22 | Alvotech announced $21 million in additional commitments for private placement (PIPE) of Oaktree II common...
10 Jan 22 | CA | Alvotech and JAMP Pharma announced that Health Canada has approved Simlandi (high-concentration,...